Answers are grounded in this paper and cite their sources.
Molecular biologic studies have now identified a number of important genetic and epigenetic mechanisms that cause alterations in growth and differentiation genes in prostate cancer. In addition to DNA deletion and point mutation, DNA methylation represents a new paradigm for the inactivation of tumor suppressor or growth suppressor genes. The identification of new genes, including a prostate cancer susceptibility locus, may furnish further insight into the molecular characteristics of prostate cancer and permit the early identification of affected individuals.
No takes yet. Share an insight, caveat, or question.
Jarrard et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: